Digestion of Intact Gluten Proteins by Bifidobacterium Species: Reduction of Cytotoxicity and Proinflammatory Responses.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: American Chemical Society Country of Publication: United States NLM ID: 0374755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5118 (Electronic) Linking ISSN: 00218561 NLM ISO Abbreviation: J Agric Food Chem Subsets: MEDLINE
    • Publication Information:
      Original Publication: Washington, American Chemical Society.
    • Subject Terms:
      Bifidobacterium/*metabolism ; Gliadin/*metabolism ; Glutens/*metabolism; Biotransformation ; Caco-2 Cells ; Celiac Disease/drug therapy ; Celiac Disease/genetics ; Celiac Disease/immunology ; Gliadin/chemistry ; Gliadin/immunology ; Glutens/immunology ; Humans ; Interleukin-1beta/genetics ; Interleukin-1beta/immunology ; Probiotics/administration & dosage ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/immunology
    • Abstract:
      Celiac disease (CD) is a chronic illness characterized by an inflammatory process triggered by gluten protein intake. Recent evidence has suggested that the lower relative abundance of bifidobacteria in the intestinal lumen may be associated with CD. Herein, we assessed the effect of the Bifidobacterium species Bifidobacterium bifidum , Bifidobacterium longum , Bembidion breve , Bifidobacterium animalis alone, and also a Bifidobacterium consortium on the digestion of intact gluten proteins (gliadins and glutenins) and the associated immunomodulatory responses elicited by the resulting peptides. The cytotoxicity and proinflammatory responses were evaluated through the activation of NF-kB p65 and the expression of cytokines TNF-α and IL-1β in Caco-2 cell cultures exposed to gluten-derived peptides. The peptides induced a clear reduction in cytotoxic responses and proinflammatory marker levels compared to the gluten fragments generated during noninoculated gastrointestinal digestion. These results highlight the possible use of probiotics based on bifidobacteria as a prospective treatment for CD.
    • Contributed Indexing:
      Keywords: bifidobacteria; celiac disease; gluten proteins; gluten-derived peptides; immunomodulatory response; toxicity
    • Accession Number:
      0 (Interleukin-1beta)
      0 (Tumor Necrosis Factor-alpha)
      8002-80-0 (Glutens)
      9007-90-3 (Gliadin)
      FX065C7O71 (glutenin)
    • Publication Date:
      Date Created: 20200321 Date Completed: 20210104 Latest Revision: 20210104
    • Publication Date:
      20221213
    • Accession Number:
      10.1021/acs.jafc.0c01421
    • Accession Number:
      32195585